Prostate: High-frequency doppler US imaging for cancer detection

Radiology

Volumn 225, Issue 1, 2002, Pages 71-77

  Halpern, Ethan I ^a   Frauscher, Ferdinand ^a   Strup, Stephen E ^a   Nazarian, Levon N ^a   O'Kane, Patrick ^a   Gomella, Leonard G ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Biopsy; Prostate; Prostate neoplasms; US

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DOPPLER FLOWMETRY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; TRANSRECTAL ULTRASONOGRAPHY;

EID: 0036789139     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2251011938     Document Type: Article

References (45)

1. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989; 142:71- 75.
2. Norberg M, Egevad L, Holmberg L, Sparen P, Norlen BJ, Busch C. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 1977; 50:562-566.
3. Eskew LA, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997; 157: 199-203.
4. Stamey TA. Making the most out of six systematic sextant biopsies. Urology 1995; 45:2-12.
5. Presti JC Jr, Chang JJ, Bhargava V, Shinohara K. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsy cores: results of a prospective clinical trial. J Urol 2000; 163:163-166.
6. Gore JL, Shariat SF, Miles BJ, et al. Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol 2001; 165:1554-1559.
7. Bigler SA, Deering RE, Brawer MK. Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum Pathol 1993; 24:220-226.
8. Donnelly EF, Geng L, Wojcicki WE, Fleischer AC, Hallahan DE. Quantified power Doppler US of tumor blood flow correlates with microscopic quantification of tumor blood vessels. Radiology 2001; 219:166-170.
9. Rifkin MD, Sudakoff GS, Alexander AA. Prostate: techniques, results, and potential applications of color Doppler US scanning. Radiology 1993; 186:509-513.
10. Kelly IMG, Lees WR, Rickards D. Prostate cancer and the role of color Doppler US. Radiology 1993; 189:153-156.
11. Newman JS, Bree RL, Rubin JM. Prostate cancer: diagnosis with color Doppler sonography with histologic correlation of each biopsy site. Radiology 1995; 195: 86-90.
12. Lavoipierre AM, Snow RM, Frydenberg M, et al. Prostatic cancer: role of Doppler imaging in transrectal sonography. AJR Am J Roentgenol 1998; 171:205-210.
13. Shigeno K, Igawa H, Shiina H, Wada H, Yoneda T. The role of colour Doppler ultrasonography in detecting prostate cancer. BJU Int 2000; 86:229-233.
14. Cornud F, Hamida K, Flam T, et al. Endorectal color Doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: correlation with radical prostatectomy findings. AJR Am J Roentgenol 2000; 175:1161-1168.
15. Downey DB, Fenster A. Three-dimensional power Doppler detection of prostatic cancer (letter). AJR Am J Roentgenol 1995; 165:741.
16. Sakarya ME, Arslan H, Unal O, Atilla MK, Aydin S. The role of power Doppler ultrasonography in the diagnosis of prostate cancer: a preliminary study. Br J Urol 1998; 82:386-388.
17. Okihara K, Kojima M, Nakanouchi T, Okada K, Midi T. Transrectal power Doppler imaging in the detection of prostate cancer. BJU Int 2000; 85:1053-1057.
18. Bree RL. The role of color Doppler and staging biopsies in prostate cancer detection. Urology 1997; 49(3A suppl):31-34.
19. Cornud F, Belin X, Piron D, et al. Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: impact on Gleason score for nonpalpable lesions. Urology 1997; 49:709-715.
20. Halpern EJ, Strup SE. Using gray-scale and color and power Doppler sonography to detect prostatic cancer. AJR Am J Roentgenol 2000; 174:623-627.
21. Chang JJ, Shinohara K, Bhargava V, Presti JC Jr. Prospective evaluation of lateral biopsy cores of the peripheral zone for prostate cancer detection. J Urol 1998; 160: 2111-2114.
22. Ravery V, Goldblatt L, Royer B, Blanc E, Toublanc M, Boccon-Gibod L. Extensive biopsy protocol improves the detection rate of prostate cancer. J Urol 2000; 164: 393-396.
23. Stewart CS, Leibovich BC, Weaver AL, Lieber MM. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001; 166:86-92.
24. Taylor KJ, Holland S. Doppler US. I. Basic principles, instrumentation, and pitfalls. Radiology 1990; 174:297-307.
25. Mitchell DG. Color Doppler imaging: principles, limitations, and artifacts. Radiology 1990; 177:1-10.
26. Halpern EJ, Frauscher F, Forsberg F, et al. High-frequency Doppler US of the prostate: effect of patient position. Radiology 2002; 222:634-639.
27. Brawer MK. Prostate cancer (editorial). J Urol 1997; 157:207-208.
28. Djavan B, Zlotta AR, Ekane S, et al. Is one set of sextant biopsies enough to rule out prostate cancer? influence of transition and total prostate volumes on prostate cancer yield. Eur Urol 2000; 38:218-224.
29. Littrup PJ, Williams CR, Egglin TK, Kane RA. Determination of prostate volume with transrectal US for cancer screening. Radiology 1991; 179:49-53.
30. Obuchowski NA. Nonparametric analysis of clustered ROC curve data. Biometrics 1997; 53:567-578.
31. Neumaier CE, Martinoli C, Derchi LE, Silvestri E, Rosenberg I. Normal prostate gland: examination with color Doppler US. Radiology 1995; 196:453-457.
32. Leventis AK, Shariat SF, Utsunomiya T, Slawin KM. Characteristics of normal prostate vascular anatomy as displayed by power Doppler. Prostate 2001; 46:281-288.
33. Weidner N, Carroll PR, Flax J, Blumenfeld W, Foldman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993; 143:401-409.
34. Fregene TA, Khanuja PS, Noto AC, et al. Tumor-associated angiogenesis in prostate cancer. Anticancer Res 1993; 13: 2377-2382.
35. Brawer MK, Deering RE, Brown M, Preston SD, Bigler SA. Predictors of pathologic stage in prostatic carcinoma: the role of neovascularity. Cancer 1994; 73:678-687.
36. Bostwick DG, Wheeler TM, Blute M, et al. Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies. Urology 1996; 48:47-57.
37. Lissbrant IF, Stattin P, Damber JE, Bergh A. Vascular density is a predictor of cancer-specific survival in prostatic carcinoma. Prostate 1997; 33:38-45.
38. Borre M, Offersen BV, Nerstrom B, Overgaard J. Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting. Br J Cancer 1998; 78:940-944.
39. Louvar E, Littrup PJ, Goldstein A, Yu L, Sakr W, Grignon D. Correlation of color Doppler flow in the prostate with tissue microvascularity. Cancer 1998; 83:135-140.
40. Moskalik AP, Rubin MA, Wojno KJ, et al. Analysis of three-dimensional Doppler ultrasonographic quantitative measures for the discrimination of prostate cancer. J Ultrasound Med 2001; 20:713-722.
41. Frauscher F, Klauser A, Halpern EJ. Contrast-enhanced transrectal ultrasound of the prostate: clinical utility and future applications for detection of prostate cancer. Electromedica 2000; 68:29-34.
42. Bogers HA, Sedelaar JPM, Beerlage HP, et al. Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: correlation with biopsy outcome. Urology 1999; 54:97-104.
43. Frauscher F, Klauser A, Halpern EJ, Horninger W, Bartsch G. Detection of prostate cancer with a microbubble ultrasound contrast agent. Lancet 2001; 357:1849-1850.
44. Sedelaar JP, van Leenders GJ, Hulsbergenvan de Kaa CA, et al. Microvessel density: correlation between contrast ultrasonography and histology of prostate cancer. Eur Urol 2001; 40:285-293.
45. Strohmeyer D, Frauscher F, Klauser A, et al. Contrast-enhanced transrectal color Doppler ultrasonography for assessment of angiogenesis in prostate cancer. Anticancer Res 2001; 21:2907-2914.